NR 508 Week 5 Quiz Study Guide for Preparation

  • NR 508 Week 5 Quiz Study Guide for Preparation
  • $39.00


Institution Chamberlain
Contributor Richard

NR 508 Week 5 Quiz 3

  1. Which of the following agents is useful in treating angina but is avoided in patients with heart failure and atrioventricular nodal conduction abnormalities due to its significant effects of myocardial contractile force: (therapeutic effects and adverse)
  2. Which is the anti-lipidemic agent that competitively inhibits HMG CoA reductase enzymes in the biosynthesis of cholesterol? (Dynamics, mechanism)
  3. DM is a 46 y/o female with diabetes. Her medicine was recently changed to a high HGA1c. One month later she starts to develop reoccurring vaginal candidiasis. Which of the following may be responsible?
  4. Which of the following is an antianginal agent believed to reduce myocardial oxygen demand by its effects of vascular smooth muscle calcium channels? (dynamics, mechanism)
  5. A patient on an antihypertensive drug comes to your office complaining of dry cough. You switched the patient to another drug that inhibits similar pharmacologic mechanisms, and now the pt does not complain of dry cough anymore. Which is the drug that the patient is currently on? (Adverse ACE inhibitors)

 

NR 508 Week 5 Quiz Study Guide

Below is a study guide for this week's quiz that you may utilize in preparation/studying.

  1. What is the preferred ………..?
  2. What vitamin deficiency ………..?
  3. Which antihypertensives ………..?
  4. Which antihypertensives are preferred …………..?
  5. SGLT2 inhibitor side effects, including risk of diabetic ketoacidosis, ……..
  6. If a patient is in the ICU, ………..?
  7. What are the uses of an osmotic ………..?
  8. What are uses of carbonic anhydrase ………..? What are the names of the ……..?
  9. Which diuretics (Names) are aldosterone …………..?
  10. What diuretic might …………..?
  11. What is the preferred diuretic in ………..?
  12. What is the MOA for drugs used for  ………..? (sodium nitroprusside, labetalol, fenoldopam, clevidipine, esmolol)
  13. Which antihypertensive is associated …………..?
  14. What is the MOA of ………..?
  15. Which antihypertensive causes …………..?
  16. What is the MOA, side effects …………..?
  17. Which BB is a very short acting IV medication …………
  18. What are the serious side effects, and MOA ……..?
  19. What is the MOA of Ezetimibe and Fenofibrate …..?
  20. What are the side ………..?
  21. Why should a person using a transdermal nitrate …………..?
  22. What is the MOA …………..?
  23. What are the different ……….. CCBs? Which ones (by name) ………..?
  24. What different classes of drugs (and names) ……………..?
  25. Which CCBs should be avoided in those with heart …………..?

 

NR 508 Week 5 Study Guide

DM:

  1. Preferred oral agent for DM Type 2
  2. Vitamin deficiency associated with metformin use;
  3. Managing glucose in the ICU setting with insulin goal of 140-180 rather than oral agents and lower therapy goals;  ( ch 53, pg 590-598) Epocreates
  4. Adverse effects of Oral agents (see lecture),
  5. Risks associated with SGLT2 inhibitors (amputations, acidosis, yeast/mycotic infections, some cases of renal injury and hyperkalemia)

CV: 

  1.  preferred antihypertensives in African American patients;
  2. preferred antihypertensives in those with chronic kidney disease (regardless of race);  
  3. types of antihypertensives and their uses; know the agents by name and class, review the diuretic classes including specific names in each class, uses of the various types and side effects of acetazolamide, ethacrynic acid, spironolactone, triameterene) (this was part of previous reading but is again covered this week since many are used as adjuncts (or primary tx if thiazides) for HTN);
  4. therapeutic use of mannitol (Osmitrol);
  5. therapeutic use of acetazolamide;
  6.  Eplerenone MOA and use.
  7. Which diuretic can be used in those with recurrent calcium stones?
  8. If a patient has HTN, CHF and renal failure, which diuretic is most effective?
  9. Which diuretic is a mineralocorticoid antagonist?
  10. Which diuretic is a carbonic anhydrase inhibitor used to treat altitude sickness?
  11. Fenoldopam ( Corlopam) MOA and use;
  12. serious adverse effects associated with hydralazine;  
  13. which BB has alpha blocking action and non-selective BB action?
  14. What is the MOA of alpha methyl dopa?
  15. Which vasodilating antihypertensive promotes hair growth?
  16. Prazosin MOA, contraindications, adverse effects?
  17. What is the MOA of Esmolol ( Brevibloc) and when is it used?
  18. If a patient develops cough on an ACEI what similar class can we switch to that is less likely to cause cough?
  19. What classes are the following antihypertensives: Losartan, Propranolol, Enalapril, minoxidil; 
  20. What are the 2 CCBs that slow heart conduction?
  21. What are the uses of nifedipine and what is its MOA?
  22. If someone is using nitroglycerin patches, how can they avoid nitrate tolerance?  
  23. What is the MOA of nitroglycerin?

Lipid management:

  1. antihyperlipidemic agents- What is the MOA and what are the serious adverse effects of statins?
  2. What are some names of specific statin drugs?
  3. What is the MOA of ezetimibe?
  4. What is the MOA of Fenofibrate?
  5. What are the side effects of niacin?

 

Thyroid

  1. : know lab values and basic treatments of hypo- and hyperthyroidism

 

 

Instituition / Term
Term Summer 2018
Institution Chamberlain
Contributor Richard
 

Related Products

NR 508 Week 6 Quiz

$29.00

NR 508 Week 1 Outline

$25.00

xNR 508 Test Your Knowledge

$15.00